Drugs / PARENT OF CARDIOPET
PARENT OF CARDIOPET
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00413647 | Sep 2006 → Feb 2008 | coronary artery disorder | Fluoropharma, Inc. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01826773 | Mar 2013 → Jul 2016 | coronary artery disorder | Fluoropharma, Inc. | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PARENT OF CARDIOPET | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594729 ↗ |
| Known as | (18f fcpha) | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594729 ↗ |
| Known as | CardioPET | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01826773 ↗ |
| Modality | Diagnostic / imaging agent | “CardioPET™ as a PET tracer for Detection of Coronary Artery Disease” NCT00413647 ↗ |
| Route | Intravenous | “CardioPET™ will be intravenously injected” NCT01826773 ↗ |